SRx Global Inc

SRx Global Inc(SRXH)股票分析

$0.811

+0.011 (+1.39%)收盤時

Loading chart…
最高
0.838
開盤
0.808
成交量加權均價
0.81
成交量
280.74K
市值
—
最低
0.790
成交金額
228.26K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others.

AI 分析 of SRx Global Inc (SRXH)

賣出

Currently, SRx Health Solutions Inc (SRXH) is not a good buy. The stock has experienced a drastic year-to-date decline of 94.32% and a 5-day change of -19.69%, indicating severe downward momentum. The RSI is at a low 10.521, suggesting the stock is oversold but also reflecting weak demand. Additionally, the forward P/E ratio is 0, indicating a lack of expected earnings growth. The main risk is the significant debt burden reflected in the current ratio of 27.55, which, while indicating liquidity, shows a volatile financial position. Given these factors, it is advisable to avoid purchasing SRXH at this time.

估值指標

SRx Global Inc(SRXH)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 SRXH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%SRXH

$0.65

情境價格

基

基準

基準 · 50%SRXH

$0.61

情境價格

悲

悲觀

悲觀 · 25%SRXH

$0.58

情境價格

事件時間軸

2026-08-04 (ET)

05:30:00

SRX Global Acquires Stake in Vistagen

2026-07-30 (ET)

14:30:00

SRX Global Acquires Shares in Jersey Mike's IPO

2026-07-09 (ET)

12:00:00

SRx Global Inc Trading Halted, News Pending

12:00:00

SRX Global Authorizes Repurchase of Up to 10M Shares

2026-07-08 (ET)

14:00:00

SRx Global Inc Trading Halted, News Pending

資訊

SRXH 常見問題 —— 由 Alphio AI 解答

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others. It operates in the Technology sector.

Currently, SRx Health Solutions Inc (SRXH) is not a good buy. The stock has experienced a drastic year-to-date decline of 94.32% and a 5-day change of -19.69%, indicating severe downward momentum. The RSI is at a low 10.521, suggesting the stock is oversold but also reflecting weak demand. Additionally, the forward P/E ratio is 0, indicating a lack of expected earnings growth. The main risk is the significant debt burden reflected in the current ratio of 27.55, which, while indicating liquidity, shows a volatile financial position. Given these factors, it is advisable to avoid purchasing SRXH at this time.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易